---
title: Recent Posts
---

- [Our Customers and Partners](http://www.congenica.com/our-customers)
- [Our Product Portfolio](http://www.congenica.com/congenica-products) 
    - **Inherited Diseases** 
          - [Rare Disease](http://www.congenica.com/congenica-rare-disease)
          - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer)
          - [Prenatal Health](http://www.congenica.com/congenica-prenatal)
          - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening)
          - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro)
    - **Somatic Oncology** 
          - [Solid Tumours](http://www.congenica.com/congenica-oncology)
    - **Pathogen** 
          - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance)
- [Our Services](http://www.congenica.com/congenica-services) 
    - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services)
    - [Professional Services](http://www.congenica.com/professional-services)
    - [Customer Support](http://www.congenica.com/customer-support)
    - [Pharma Services](http://www.congenica.com/pharma-services)
- Resources 
    - [Publications](http://www.congenica.com/publications)
    - [Supporting materials](http://www.congenica.com/resources)
    - [News](https://blog.congenica.com/)
    - [Events and webinars](http://www.congenica.com/events-webinars)
- [About us](http://www.congenica.com) 
    - [Leadership Team](http://www.congenica.com/leadership)
    - [Quality](http://www.congenica.com/quality)
    - [Investors](http://www.congenica.com/investors)
    - [People and Vacancies](http://www.congenica.com/people)
- [Contact us](http://www.congenica.com/contact)

Login

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

# Latest News and Blogs

![SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/hs-fs/hubfs/New%20logos/Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png?width=320&height=192&name=Congenica%20%26%20SeqOne%20Logo%20Without%20Tagline%20RGB.png)

 9/2/2025

#### [SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine](https://blog.congenica.com/seqone-acquires-congenica-to-create-a-global-leader-in-ai-powered-genomic-medicine)

Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries

![Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/hs-fs/hubfs/male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg?width=320&height=192&name=male%20doc%20with%20child%20and%20mum%20light%20small%20.jpg)

 11/6/2024

#### [Congenica showcased in Genomics Spotlight 2024 Report](https://blog.congenica.com/congenica-showcased-in-recently-launched-genomics-spotlight-2024-report)

We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).

![Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/hs-fs/hubfs/Onco%20.png?width=320&height=192&name=Onco%20.png)

 6/19/2024

#### [Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP](https://blog.congenica.com/congenica-named-best-genomic-data-analysis-software-company-2024-by-ghp)

We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine. 

![Congenica selected for final phase of Instand-NGS4P](https://blog.congenica.com/hs-fs/hubfs/Onco%20.png?width=320&height=192&name=Onco%20.png)

 5/21/2024

#### [Congenica selected for final phase of Instand-NGS4P](https://blog.congenica.com/congenica-selected-for-final-phase-of-instand-ngs4p)

Congenica has been selected for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology.

![Congenica secures new two-year contract with Hong Kong Genome Project](https://blog.congenica.com/hs-fs/hubfs/Untitled%20design%20-%202023-10-04T140704.962.png?width=320&height=192&name=Untitled%20design%20-%202023-10-04T140704.962.png)

 10/4/2023

#### [Congenica secures new two-year contract with Hong Kong Genome Project](https://blog.congenica.com/congenica-secures-new-two-year-contract-with-hong-kong-genome-project)

Congenica announces a two-year extension to their contract with the Hong Kong Genome Project (HKGP).

![Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials](https://blog.congenica.com/hs-fs/hubfs/Together%20Driving%20Precision%20Oncology%20(744%20%C3%97%20400%20px).png?width=320&height=192&name=Together%20Driving%20Precision%20Oncology%20(744%20%C3%97%20400%20px).png)

 9/13/2023

#### [Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials](https://blog.congenica.com/congenica-and-mytomorrows-announce-partnership-to-advance-precision-oncology)

Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.

![Congenica co-founder Professor Richard Durbin awarded the 39th International Prize for Biology](https://blog.congenica.com/hs-fs/hubfs/Add%20a%20title%20(2).png?width=320&height=192&name=Add%20a%20title%20(2).png)

 9/5/2023

#### [Congenica co-founder Professor Richard Durbin awarded the 39th International Prize for Biology](https://blog.congenica.com/richard-durbin-awarded-39th-international-prize-for-biology)

Congenica Informatics Director Richard Durbin has been awarded the International Prize for Biology by the Japan Society of the Promotion of Science.

![Congenica and NoorDx deliver sample-to-report services across the Middle East](https://blog.congenica.com/hs-fs/hubfs/NoorDX%20announcement.png?width=320&height=192&name=NoorDX%20announcement.png)

 6/22/2023

#### [Congenica and NoorDx deliver sample-to-report services across the Middle East](https://blog.congenica.com/congenica-noordx-deliver-sample-to-report-services-across-middleeast)

Congenica announces a strategic partnership with NoorDx, an innovative clinical genomics and research services company in Saudi Arabia.

![The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology](https://blog.congenica.com/hs-fs/hubfs/The%20art%20of%20genomic%20winnowing%20-%20there%20is%20still%20much%20to%20do%20to%20unlock%20the%20full%20potential%20of%20precision%20oncology.png?width=320&height=192&name=The%20art%20of%20genomic%20winnowing%20-%20there%20is%20still%20much%20to%20do%20to%20unlock%20the%20full%20potential%20of%20precision%20oncology.png)

 3/14/2023

#### [The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology](https://blog.congenica.com/the-art-of-genomic-winnowing-to-unlock-the-full-potential-of-precision-oncology)

Philip Beer presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.

![The time has come to change the way we treat cancer](https://blog.congenica.com/hs-fs/hubfs/Transforming%20Cancer%20Care%20Using%20Genomic%20Tests%20(2).png?width=320&height=192&name=Transforming%20Cancer%20Care%20Using%20Genomic%20Tests%20(2).png)

 3/7/2023

#### [The time has come to change the way we treat cancer](https://blog.congenica.com/time-to-change-the-way-we-treat-cancer)

Professor Andrew Biankin shares his experiences in transforming cancer care with genomic testing.

![The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients](https://blog.congenica.com/hs-fs/hubfs/Untitled%20design%20(8).png?width=320&height=192&name=Untitled%20design%20(8).png)

 2/24/2023

#### [The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients](https://blog.congenica.com/the-road-to-diagnosis-how-genetics-transforms-the-lives-of-rare-disease-patients)

In recognition of Rare Disease Day, Congenica looks at the importance of a genetic diagnosis for patients and asks, what's next for rare disease?

![Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute](https://blog.congenica.com/hs-fs/hubfs/Deciphering%20Developmental%20Disorders%20(2).png?width=320&height=192&name=Deciphering%20Developmental%20Disorders%20(2).png)

 2/15/2023

#### [Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute](https://blog.congenica.com/matt-hurles-director-of-the-wellcome-sanger-institute)

Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute. 

##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.

- [Privacy Policy](http://www.congenica.com/privacy-policy)
- [Cookie Policy](http://www.congenica.com/cookie-policy)

<https://twitter.com/congenica> <https://en-gb.facebook.com/congenica/> <https://www.linkedin.com/company/congenica/> 

Log in to Congenica

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png)

Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.